Jodi L Smith

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Major Depressive Disorder

Prognostic Factors

Top Venues

Expert opinion on drug discovery

Expert review of clinical pharmacology

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey M Witkin, Lalit K Golani, Jodi L Smith
Clinical pharmacological innovation in the treatment of depression. Expert review of clinical pharmacology (2023)
Andrzej Pilc, Agata Machaczka, Paweł Kawalec, Jodi L Smith, Jeffrey M Witkin
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Expert opinion on drug discovery 17 (10) (2022)
Daniel E Knutson, Jodi L Smith, Xingjie Ping, Xiao-Ming Jin, Lalit K Golani, Guanguan Li, Veera Venkata Naga Phani Babu Tiruveedhula, Farjana Rashid, Md Yeunus Mian, Rajwana Jahan, Dishary Sharmin, Rok Cerne, James M Cook, Jeffrey M Witkin
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects. ACS chemical neuroscience 11 (17) (2020)